Pyrazinamide

Product NDC
70518-2534
11-digit product format
705182534
Labeler code
70518
Product ID
70518-2534_c9eaaafb-7add-a17c-e053-2995a90a1399
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Pyrazinamide
Dosage form
TABLET
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA081319
Marketing category
ANDA
Marketing start
2020-01-10
Marketing end
0000-00-00
Substance
PYRAZINAMIDE
Active strength
500 mg/1
Pharmacologic classes
Antimycobacterial [EPC]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-2534-02023-02-15C16284748780-1f386c649-99c0-0266-e053-dadaa90a7c1a54b6665c-dc8a-458c-96bc-c6bcf34a41c6
70518-2534-02023-01-30C16284748780-1f386c649-99c0-0266-e053-dadaa90a7c1a54b6665c-dc8a-458c-96bc-c6bcf34a41c6

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-2534-07051825340030 TABLET in 1 BLISTER PACK (70518-2534-0) 30 tablet2020-01-100000-00-00NoNoCurrent